Search Results - "Hyde, Matthew A."

Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection by Engdahl, Taylor B., Kuzmina, Natalia A., Ronk, Adam J., Mire, Chad E., Hyde, Matthew A., Kose, Nurgun, Josleyn, Matthew D., Sutton, Rachel E., Mehta, Apoorva, Wolters, Rachael M., Lloyd, Nicole M., Valdivieso, Francisca R., Ksiazek, Thomas G., Hooper, Jay W., Bukreyev, Alexander, Crowe, James E.

“…New World hantaviruses (NWHs) are endemic in North and South America and cause hantavirus cardiopulmonary syndrome (HCPS), with a case fatality rate of up to…”
Get full text

A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection by Malherbe, Delphine C., Domi, Arban, Hauser, Mary J., Atyeo, Caroline, Fischinger, Stephanie, Hyde, Matthew A., Williams, Julie M., Alter, Galit, Guirakhoo, Farshad, Bukreyev, Alexander

“…A new vectored vaccine MVA-VLP-SUDV was generated against Sudan ebolavirus (SUDV) combining the advantages of the immunogenicity of a live attenuated vaccine…”
Get full text

A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19 by Malherbe, Delphine C., Kurup, Drishya, Wirblich, Christoph, Ronk, Adam J., Mire, Chad, Kuzmina, Natalia, Shaik, Noor, Periasamy, Sivakumar, Hyde, Matthew A., Williams, Julie M., Shi, Pei-Yong, Schnell, Matthias J., Bukreyev, Alexander

“…The development of effective countermeasures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the COVID-19…”
Get full text

Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system by Ilinykh, Philipp A., Huang, Kai, Gunn, Bronwyn M., Kuzmina, Natalia A., Kedarinath, Kritika, Jurado-Cobena, Eduardo, Zhou, Fuchun, Subramani, Chandru, Hyde, Matthew A., Velazquez, Jalene V., Williamson, Lauren E., Gilchuk, Pavlo, Carnahan, Robert H., Alter, Galit, Crowe, James E., Bukreyev, Alexander

Get full text

Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system by Ilinykh, Philipp A., Huang, Kai, Gunn, Bronwyn M., Kuzmina, Natalia A., Kedarinath, Kritika, Jurado-Cobena, Eduardo, Zhou, Fuchun, Subramani, Chandru, Hyde, Matthew A., Velazquez, Jalene V., Williamson, Lauren E., Gilchuk, Pavlo, Carnahan, Robert H., Alter, Galit, Crowe, James E., Bukreyev, Alexander

“…Antibodies to Ebola virus glycoprotein (EBOV GP) represent an important correlate of the vaccine efficiency and infection survival. Both neutralization and…”
Get full text

Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection by Baldeon Vaca, Gabriela, Meyer, Michelle, Cadete, Ana, Hsiao, Chiaowen Joyce, Golding, Anne, Jeon, Albert, Jacquinet, Eric, Azcue, Emily, Guan, Chenxia Monica, Sanchez-Felix, Xavier, Pietzsch, Colette A., Mire, Chad E., Hyde, Matthew A., Comeaux, Margaret E., Williams, Julie M., Sung, Jean C., Carfi, Andrea, Edwards, Darin K., Bukreyev, Alexander, Bahl, Kapil

“…Intranasal vaccination represents a promising approach for preventing disease caused by respiratory pathogens by eliciting a mucosal immune response in the…”
Get full text

Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection by Engdahl, Taylor B., Kuzmina, Natalia A., Ronk, Adam J., Mire, Chad E., Hyde, Matthew A., Kose, Nurgun, Josleyn, Matthew D., Sutton, Rachel E., Mehta, Apoorva, Wolters, Rachael M., Lloyd, Nicole M., Valdivieso, Francisca R., Ksiazek, Thomas G., Hooper, Jay W., Bukreyev, Alexander, Crowe, James E.

Get full text

Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement by Ilinykh, Philipp A., Huang, Kai, Gunn, Bronwyn M., Kuzmina, Natalia A., Kedarinath, Kritika, Jurado-Cobena, Eduardo, Zhou, Fuchun, Subramani, Chandru, Hyde, Matthew A., Velazquez, Jalene V., Williamson, Lauren E., Gilchuk, Pavlo, Carnahan, Robert H., Alter, Galit, Crowe, James E., Bukreyev, Alexander

“…Antibodies to Ebola virus glycoprotein (EBOV GP) represent an important correlate of the vaccine efficiency and infection survival. Both neutralization and…”
Get full text